Literature DB >> 25667180

Acute respiratory distress syndrome in the global context.

Egide Buregeya1, Robert A Fowler2, Daniel S Talmor3, Theogene Twagirumugabe1, Willy Kiviri1, Elisabeth D Riviello4.   

Abstract

Acute respiratory distress syndrome (ARDS) is a clinically defined syndrome of hypoxia and bilateral pulmonary infiltrates due to inflammatory pathways triggered by pulmonary and nonpulmonary insults, and ARDS is pathologically correlated with diffuse alveolar damage. Estimates of ARDS's impact in the developed world vary widely, with some of the discrepancies attributed to marked differences in the availability of intensive care beds and mechanical ventilation. Almost nothing is known about the epidemiology of ARDS in the developing world, in part due to a clinical definition requiring positive pressure ventilation, arterial blood gases, and chest radiography. Current frameworks for comparing the epidemiology of death and disability across the world including the GBD (Global Burden of Disease Study) 2010 are ill-suited to quantifying critical illness syndromes including ARDS. Modifications to the definition of ARDS to allow a provision for environments without the capacity for positive pressure ventilation, and to allow for alternate diagnostic techniques including pulse oximetry and ultrasound, may make it possible to quantify and describe the impact of ARDS in the global context.
Copyright © 2014 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25667180     DOI: 10.1016/j.gheart.2014.08.003

Source DB:  PubMed          Journal:  Glob Heart        ISSN: 2211-8160


  11 in total

1.  Auricularia auricular-judae polysaccharide attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and inflammation.

Authors:  L I Zhuan-Yun; Yao Xue-Ping; Liu Bin; Ha Nizaier Reheman; Gao Yang; Sun Zhan; M A Qi
Journal:  Biomed Rep       Date:  2015-05-26

2.  From Berlin to Kigali: the sobering journey of acute respiratory distress syndrome.

Authors:  Thomas Bein
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  The Kigali modification of the berlin definition: a new epidemiological tool for ARDS?

Authors:  Chiara Lazzeri; Adriano Peris
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 4.  Pulmonary Endothelial Cell Apoptosis in Emphysema and Acute Lung Injury.

Authors:  Eboni Chambers; Sharon Rounds; Qing Lu
Journal:  Adv Anat Embryol Cell Biol       Date:  2018       Impact factor: 1.231

5.  Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

Authors:  Nan Li; Dong Weng; Shan-Mei Wang; Yuan Zhang; Shan-Shan Chen; Zhao-Fang Yin; Jiali Zhai; Judy Scoble; Charlotte C Williams; Tao Chen; Hui Qiu; Qin Wu; Meng-Meng Zhao; Li-Qin Lu; Xavier Mulet; Hui-Ping Li
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  What's new in ARDS: ARDS also exists in resource-constrained settings.

Authors:  Elisabeth D Riviello; Luigi Pisani; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2016-03-16       Impact factor: 17.440

7.  Health Professional Training and Capacity Strengthening Through International Academic Partnerships: The First Five Years of the Human Resources for Health Program in Rwanda.

Authors:  Corrado Cancedda; Phil Cotton; Joseph Shema; Stephen Rulisa; Robert Riviello; Lisa V Adams; Paul E Farmer; Jeanne N Kagwiza; Patrick Kyamanywa; Donatilla Mukamana; Chrispinus Mumena; David K Tumusiime; Lydie Mukashyaka; Esperance Ndenga; Theogene Twagirumugabe; Kaitesi B Mukara; Vincent Dusabejambo; Timothy D Walker; Emmy Nkusi; Lisa Bazzett-Matabele; Alex Butera; Belson Rugwizangoga; Jean Claude Kabayiza; Simon Kanyandekwe; Louise Kalisa; Faustin Ntirenganya; Jeffrey Dixson; Tanya Rogo; Natalie McCall; Mark Corden; Rex Wong; Madeleine Mukeshimana; Agnes Gatarayiha; Egide Kayonga Ntagungira; Attila Yaman; Juliet Musabeyezu; Anne Sliney; Tej Nuthulaganti; Meredith Kernan; Peter Okwi; Joseph Rhatigan; Jane Barrow; Kim Wilson; Adam C Levine; Rebecca Reece; Michael Koster; Rachel T Moresky; Jennifer E O'Flaherty; Paul E Palumbo; Rashna Ginwalla; Cynthia A Binanay; Nathan Thielman; Michael Relf; Rodney Wright; Mary Hill; Deborah Chyun; Robin T Klar; Linda L McCreary; Tonda L Hughes; Marik Moen; Valli Meeks; Beth Barrows; Marcel E Durieux; Craig D McClain; Amy Bunts; Forrest J Calland; Bethany Hedt-Gauthier; Danny Milner; Giuseppe Raviola; Stacy E Smith; Meenu Tuteja; Urania Magriples; Asghar Rastegar; Linda Arnold; Ira Magaziner; Agnes Binagwaho
Journal:  Int J Health Policy Manag       Date:  2018-11-01

8.  The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo.

Authors:  Shuling Hu; Jinze Li; Xiuping Xu; Airan Liu; Hongli He; Jingyuan Xu; Qihong Chen; Songqiao Liu; Ling Liu; Haibo Qiu; Yi Yang
Journal:  Stem Cell Res Ther       Date:  2016-04-29       Impact factor: 6.832

9.  The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo.

Authors:  Yi Yang; Shuling Hu; Xiuping Xu; Jinze Li; Airan Liu; Jibin Han; Songqiao Liu; Ling Liu; Haibo Qiu
Journal:  Mediators Inflamm       Date:  2016-05-24       Impact factor: 4.711

Review 10.  Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.

Authors:  Gurupreet S Sethi; Vivek Dharwal; Amarjit S Naura
Journal:  Front Immunol       Date:  2017-09-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.